Key Financials | KlickAnalytics

Global Standardized Financials

5.67 0.22(3.95%)12/09/2025
Candel Therapeutics, Inc. (CADL)

Limited Financial Data is shown. To view all data, Upgrade to PRO plan!

Income Statement

(Values in Thousands)

	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023	Q3 2023 Sep 30, 2023	Q2 2023 Jun 30, 2023	Q1 2023 Mar 31, 2023	Q4 2022 Dec 31, 2022	Q3 2022 Sep 30, 2022	Q2 2022 Jun 30, 2022	Q1 2022 Mar 31, 2022	Q4 2021 Dec 31, 2021	Q3 2021 Sep 30, 2021	Q2 2021 Jun 30, 2021	Q1 2021 Mar 31, 2021	Q4 2020 Dec 31, 2020	Q3 2020 Sep 30, 2020	Q2 2020 Jun 30, 2020	Q1 2020 Mar 31, 2020
Net Income	-4,796	7,379	-14,073	-10,646	-22,237	-8,221	-11,095	-8,435
Revenue			1,000				1,776
Cost Of Revenue	242	245	245	245	249	251	312	306
Gross Profit	-242	-245	-245	-245	-249	-251	1,464	-306
Operating Expenses	11,177	7,885	7,896	8,757	8,571	7,651	10,006	8,861
Selling General and Administrative Expenses	4,186	4,114	3,324	3,341	3,592	3,800	3,060	3,016
Research and Development Expenses	6,991	4,016	4,817	5,416	4,979	3,851	6,946	5,845
Other Expenses		-245	-245				12
Cost And Expenses	11,177	8,130	8,141	8,757	8,571	7,902	10,318	8,861
Operating Income	-11,177	-8,130	-8,141	-8,757	-8,571	-7,902	-10,318	-8,861
Interest Income	926	934	290	236	240	320	415	502
Income Tax Expense							386	-90
Income Before Tax	-4,796	7,379	-14,073	-10,646	-22,237	-8,221	-11,095	-8,435
Earning Per Share Basic	-0.09	0.23	-0.40	-0.33	-0.74	-0.28	-0.38	-0.29
Earning Per Share Diluted	-0.09	0.23	-0.40	-0.33	-0.74	-0.28	-0.38	-0.29
weighted Average Shares Outstanding	51,490	31,675	35,565	32,014	29,878	29,198	28,981	28,920
weighted Average Shares Outstanding (Diluted)	51,490	31,675	35,565	32,014	29,878	29,198	28,981	28,920
Gross Margin			-0.25				0.82
EBIT Margin			-13.44				-5.69
Profit Margin			-14.07				-6.25
EBITDA	-4,318	-8,130	-13,438	-9,914	-21,421	-7,324	-10,110	-7,460
Earning Before Tax Margin			-14.07				-6.25